Erratum: Immunotherapy for Glioblastoma: Current Progress and Challenges
- PMID: 34691087
- PMCID: PMC8529955
- DOI: 10.3389/fimmu.2021.782687
Erratum: Immunotherapy for Glioblastoma: Current Progress and Challenges
Abstract
[This corrects the article DOI: 10.3389/fimmu.2021.676301.].
Keywords: brain cancer; glioblastoma; immunotherapy; resistance to therapy; tumor microenvironment.
Copyright © 2021 Frontiers Production Office.
Erratum for
-
Immunotherapy for Glioblastoma: Current Progress and Challenges.Front Immunol. 2021 May 13;12:676301. doi: 10.3389/fimmu.2021.676301. eCollection 2021. Front Immunol. 2021. PMID: 34054867 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources
